GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,477.00p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,071.73m
  • Volume: 9,494,117
  • Market Cap: £60,140m
  • RiskGrade: 129

Latest ShareCast News

GSK gepotidacin edges closer to landmark approval for gonorrhoea

By Iain Gilbert

Date: Monday 11 Aug 2025

(Sharecast News) - Drugmaker GSK moved closer to expanding its antibiotic portfolio on Monday, after US regulators accepted its application to review gepotidacin as a potential oral treatment for gonorrhoea.

GSK and CureVac secure $740m payout in mRNA patent settlement

By Iain Gilbert

Date: Friday 08 Aug 2025

(Sharecast News) - Drugmaker GSK said on Friday that it had reached a settlement, alongside CureVac, to resolve long-running patent litigation with BioNTech and Pfizer over mRNA-based COVID-19 vaccines.

London close: Stocks fall on Trump's latest tariffs, US jobs data

By Josh White

Date: Friday 01 Aug 2025

(Sharecast News) - London stocks ended the week lower on Friday as investors reacted to a fresh wave of US tariffs and disappointing economic data from the United States.

London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
GSK and Hengrui unveil development deal worth up... 28-Jul-2025 ShareCast
London close: FTSE finishes week just shy of 9,000 18-Jul-2025 ShareCast
FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast
US FDA approves new format of GSK's Shingrix 17-Jul-2025 ShareCast
US FDA to review GSK bid to extend use of respir... 14-Jul-2025 ShareCast
EMA accepts marketing authorisation application ... 23-Jun-2025 ShareCast
GSK hoping to expand Arexvy usage in Japan 20-Jun-2025 ShareCast
GSK's RSV vaccine accepted for regulatory review... 13-Jun-2025 ShareCast
Berenberg downgrades GSK to 'hold' ahead of prod... 03-Jun-2025 ShareCast
GSK's linerixibat to be reviewed by US FDA 02-Jun-2025 ShareCast
GSK, Spero UTI drug trial ends early after meeti... 28-May-2025 ShareCast
GSK's COPD treatment approved by FDA 23-May-2025 ShareCast
GSK's blood cancer treatment approved in Japan 19-May-2025 ShareCast
London close: Stocks finish choppy week in the b... 16-May-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,477.00p
Change Today 7.50p
% Change 0.51 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 9,494,117
Shares Issued 4,071.73m
Market Cap £60,140m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 27-Aug-2025

Time Volume / Share Price
17:31 17,280 @ 1,479.33p
10:55 1,976,000 @ 1,478.50p
10:55 1,976,000 @ 1,478.50p
16:28 1 @ 1,477.00p
15:44 3 @ 1,472.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page